SCHEMBL14033237

SCHEMBL14033237

FC1(F)Oc2cccc(C(Cl)c3ccccc3)c2O1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
CHRM4 P08173 1/20 0.30
CTNNB1 P35222 1/20 0.30
WNT3A P56704 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033848 0.84 ADORA2A (0.31)
SCHEMBL8400149 0.82 IDO1 (0.32)
SCHEMBL14033246 0.81 MEN1 (0.37) CHRM4CTNNB1WNT3A
SCHEMBL9962275 0.75 GABRA1 (0.38) TSHR
SCHEMBL23232390 0.72 CYP1A2 (0.38)
SCHEMBL3704838 0.72 CYP1A2 (0.38)
SCHEMBL18500388 0.71 IDO1 (0.37)
SCHEMBL14033759 0.71 CTNNB1 (0.43) TSHRCTNNB1WNT3A
Hydrochloric Acid SCHEMBL3697431 0.71 ALDH1A1 (0.40)
Hydrochloric Acid SCHEMBL26100881 0.71 ALDH1A1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed